Please login to the form below

Not currently logged in
Email:
Password:

brodalumab

This page shows the latest brodalumab news and features for those working in and with pharma, biotech and healthcare.

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

However, Bausch Health still retains the rights to develop and market brodalumab within the US and Canada. ... Leo Pharma has had approval for brodalumab in the EU, which it markets under the name Kyntheum, since 2017.

Latest news

More from news
Approximately 10 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    Brodalumab is phase III complete, but is thought to have been cast off due to concerns raised over links to the drug and suicidal thoughts. ... Collaboration - discovery. 500. AstraZeneca. Valeant Pharmaceuticals. Brodalumab for psoriasis, ready for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics